These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
32. Synergistic action of angiotensin II, insulin-like growth factor-I, and transforming growth factor-beta on platelet-derived growth factor-BB, basic fibroblastic growth factor, and epidermal growth factor-induced DNA synthesis in vascular smooth muscle cells. Ko Y, Stiebler H, Nickenig G, Wieczorek AJ, Vetter H, Sachinidis A. Am J Hypertens; 1993 Jun; 6(6 Pt 1):496-9. PubMed ID: 8343232 [Abstract] [Full Text] [Related]
33. Contribution of synthetic phenotype on the enhanced angiotensin II-generating system in vascular smooth muscle cells from spontaneously hypertensive rats. Fukuda N, Hu WY, Satoh C, Nakayama M, Kishioka H, Kubo A, Kanmatsuse K. J Hypertens; 1999 Aug; 17(8):1099-107. PubMed ID: 10466465 [Abstract] [Full Text] [Related]
35. Human osteosarcoma (U-2 OS) cells express both insulin-like growth factor-I (IGF-I) receptors and insulin-like growth factor-II/mannose-6-phosphate (IGF-II/M6P) receptors and synthesize IGF-II: autocrine growth stimulation by IGF-II via the IGF-I receptor. Raile K, Höflich A, Kessler U, Yang Y, Pfuender M, Blum WF, Kolb H, Schwarz HP, Kiess W. J Cell Physiol; 1994 Jun; 159(3):531-41. PubMed ID: 8188767 [Abstract] [Full Text] [Related]